CD11c+ microglia promote dysfunctional T cell activation in diffuse midline glioma
Findings identify a previously unrecognised CD11c⁺ microglia–T-cell axis that establishes immune dysfunction in DMG and provide a rationale for combining myeloid- and T cell-targeted immunotherapies.